REGN Regeneron Pharmaceuticals Inc

NASDAQStockView on Yahoo Finance ↗

$800.17

+2.32% (24h)

Updated 14:19 UTC

3 months: +19.05%Updated 14:19 UTC

Market Cap

$82.38B

24h Volume

$99.32K

1h %

—

7d %

+6.35%

Related News

Biohaven and Regeneron Expand Oncology Collaboration

Biohaven and Regeneron Expand Oncology Collaboration

Regeneron Pharmaceuticals Confirms Dividend, Focuses on Buybacks After Q2 Results

Regeneron Pharmaceuticals Confirms Dividend, Focuses on Buybacks After Q2 Results

Regeneron Pharmaceuticals Faces Class Action Lawsuit

Regeneron Pharmaceuticals Faces Class Action Lawsuit

Regeneron (REGN) May Be Undervalued After Cemdisiran Drug Review Acceptance

Regeneron (REGN) May Be Undervalued After Cemdisiran Drug Review Acceptance